Skip to main content

Table 1 Demographic and clinical data of the breast cancer studied patients and control

From: Down-regulation of MSH3 and MSH6 genes in female breast cancer patients receiving taxane-based therapy

Variable

Cases

N = 105

n, (%)

Controls

N = 50

n, (%)

Age (years)

Mean ± SD

range

53.05 ± 9.9

27.0–73.0

47.05 ± 8.9

25.0–70.0

Sex

Female (ALL)

105 (100.0%)

50 (100.0%)

Smoking

Passive

No

5(4.8)

100 (95.2)

2 (4)

48 (96)

Menopause

Post

Pre

53 (50.5)

52 (49.5)

23 (46)

27 (54)

F.H of breast cancer

Negative

Positive

77 (73.3)

28 (26.7)

35 (70)

15 (30)

ECOG-PS

1

2

93(88.6)

12 (11.4)

NA

  1. N number; F.H family history, ECOG-PS Eastern Cooperative Oncology Group performance status, NA non applicable